These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27238707)

  • 1. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction.
    Benton SJ; McCowan LM; Heazell AE; Grynspan D; Hutcheon JA; Senger C; Burke O; Chan Y; Harding JE; Yockell-Lelièvre J; Hu Y; Chappell LC; Griffin MJ; Shennan AH; Magee LA; Gruslin A; von Dadelszen P
    Placenta; 2016 Jun; 42():1-8. PubMed ID: 27238707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.
    Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction.
    Shinar S; Tigert M; Agrawal S; Parks WA; Kingdom JC
    Pregnancy Hypertens; 2021 Aug; 25():123-128. PubMed ID: 34119877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction.
    Ormesher L; Johnstone ED; Shawkat E; Dempsey A; Chmiel C; Ingram E; Higgins LE; Myers JE
    Pregnancy Hypertens; 2018 Oct; 14():234-239. PubMed ID: 29559205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental pathology lesions: International Society for Ultrasound in Obstetrics and Gynecology vs Society for Maternal-Fetal Medicine fetal growth restriction definitions.
    Rodriguez-Sibaja MJ; Lopez-Diaz AJ; Valdespino-Vazquez MY; Acevedo-Gallegos S; Amaya-Guel Y; Camarena-Cabrera DM; Lumbreras-Marquez MI
    Am J Obstet Gynecol MFM; 2024 Aug; 6(8):101422. PubMed ID: 38969177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of angiogenetic biomarkers in the detection of early onset fetal growth restriction.
    Giorgione V; Ramnarine S; Malik A; Bhide A
    Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():91-95. PubMed ID: 38850897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight.
    Kennedy LM; Tong S; Robinson AJ; Hiscock RJ; Hui L; Dane KM; Middleton AL; Walker SP; MacDonald TM
    BMC Med; 2020 Dec; 18(1):395. PubMed ID: 33357243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study.
    Gaccioli F; Sovio U; Cook E; Hund M; Charnock-Jones DS; Smith GCS
    Lancet Child Adolesc Health; 2018 Aug; 2(8):569-581. PubMed ID: 30119716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of placental biomarkers and fetoplacental Dopplers in predicting likely placental pathology in early and late fetal growth restriction - A prospective study.
    Hong J; Crawford K; Daly M; Clifton V; da Silva Costa F; Perkins AV; Matsika A; Lourie R; Kumar S
    Placenta; 2024 Oct; 156():20-29. PubMed ID: 39232442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
    Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?
    Benton SJ; Hu Y; Xie F; Kupfer K; Lee SW; Magee LA; von Dadelszen P
    Am J Obstet Gynecol; 2012 Feb; 206(2):163.e1-7. PubMed ID: 22055338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.
    Korzeniewski SJ; Romero R; Chaiworapongsa T; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L
    Am J Obstet Gynecol; 2016 May; 214(5):629.e1-629.e17. PubMed ID: 26688491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?
    Zhang K; Zen M; Popovic NL; Lee VW; Alahakoon TI
    J Obstet Gynaecol Res; 2019 Sep; 45(9):1828-1836. PubMed ID: 31257726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction.
    Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A
    Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal Growth and Placental Growth Factor Umbilical Cord Blood Levels.
    Broere-Brown ZA; Schalekamp-Timmermans S; Jaddoe VWV; Steegers EAP
    Fetal Diagn Ther; 2018; 43(1):26-33. PubMed ID: 28926825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placenta clinic approach to the diagnosis and management of fetal growth restriction.
    Kingdom JC; Audette MC; Hobson SR; Windrim RC; Morgen E
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S803-S817. PubMed ID: 29254754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
    Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.
    Shinohara S; Uchida Y; Kasai M; Sunami R
    Hypertens Pregnancy; 2017 Aug; 36(3):269-275. PubMed ID: 28737473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.